ArticleClinical and experimental immunology2018

Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines.

A Uzawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.